This inventor holds 6 USPTO granted patents and 1 published patent application. Top assignees: Abbvie Inc., H. Lundbeck A/s. Active years: 2013-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2019
Title: David Ihle: Innovator in Immunological and Oncological Treatments
Introduction
David Ihle is a prominent inventor based in Worcester, MA (US), known for his significant contributions to the field of pharmaceuticals. He holds a total of 6 patents, focusing on innovative compounds that have the potential to treat various immunological and oncological conditions.
Latest Patents
Among his latest patents, Ihle has developed indazolone compounds that serve as modulators of TNF signaling. The disclosures provide compounds of Formula (I), including pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers, and isomers. These compounds are designed to be effective in treating immunological and oncological conditions, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, David Ihle has worked with notable companies such as AbbVie Inc. and H. Lundbeck A/S. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Ihle has collaborated with esteemed colleagues, including Michael M. Friedman and Kelly Mullen. These partnerships have further enriched his work and expanded the impact of his inventions.
Conclusion
David Ihle's innovative work in developing compounds for treating serious health conditions highlights his role as a key inventor in the pharmaceutical field. His contributions continue to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile